This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Randomized Controlled Trial

. 2006 Dec;26(6):666-7.

doi: 10.1097/01.jcp.0000245562.99036.92.

Antipsychotic treatment discontinuation among individuals with schizophrenia and co-occurring substance use

David A Smelson, Sandra L Tunis, Allen W Nyhuis, Douglas E Faries, Bruce J Kinon, Haya Ascher-Svanum

PMID: 17110828
DOI: 10.1097/01.jcp.0000245562.99036.92

Randomized Controlled Trial

Antipsychotic treatment discontinuation among individuals with schizophrenia and co-occurring substance use

David A Smelson et al. J Clin Psychopharmacol. 2006 Dec.

. 2006 Dec;26(6):666-7.

doi: 10.1097/01.jcp.0000245562.99036.92.

Authors

David A Smelson, Sandra L Tunis, Allen W Nyhuis, Douglas E Faries, Bruce J Kinon, Haya Ascher-Svanum

PMID: 17110828
DOI: 10.1097/01.jcp.0000245562.99036.92

No abstract available

PubMed Disclaimer

Similar articles

Effectiveness of olanzapine, quetiapine, and risperidone in patients with chronic schizophrenia after discontinuing perphenazine: a CATIE study.
Stroup TS, Lieberman JA, McEvoy JP, Swartz MS, Davis SM, Capuano GA, Rosenheck RA, Keefe RS, Miller AL, Belz I, Hsiao JK; CATIE Investigators. Stroup TS, et al. Am J Psychiatry. 2007 Mar;164(3):415-27. doi: 10.1176/ajp.2007.164.3.415. Am J Psychiatry. 2007. PMID: 17329466 Clinical Trial.
Time to discontinuation and self-discontinuation of olanzapine and risperidone in patients with schizophrenia in a naturalistic outpatient setting.
Kilzieh N, Todd-Stenberg JA, Kennedy A, Wood AE, Tapp AM. Kilzieh N, et al. J Clin Psychopharmacol. 2008 Feb;28(1):74-7. doi: 10.1097/jcp.0b013e3181602cf3. J Clin Psychopharmacol. 2008. PMID: 18204345
Comparison of olanzapine to risperidone in substance-abusing individuals with schizophrenia.
Akerele E, Levin FR. Akerele E, et al. Am J Addict. 2007 Jul-Aug;16(4):260-8. doi: 10.1080/10550490701389658. Am J Addict. 2007. PMID: 17661193 Clinical Trial.
[Treatment of schizophrenia in subjects with substance use disorders: A review].
Rubio Valladolid G, Casas Brugué M. Rubio Valladolid G, et al. Actas Esp Psiquiatr. 2001 Mar-Apr;29(2):124-30. Actas Esp Psiquiatr. 2001. PMID: 11333531 Review. Spanish.
Management of schizophrenia with substance use disorders.
Lybrand J, Caroff S. Lybrand J, et al. Psychiatr Clin North Am. 2009 Dec;32(4):821-33. doi: 10.1016/j.psc.2009.09.002. Psychiatr Clin North Am. 2009. PMID: 19944886 Review.

See all similar articles

Cited by

Treatment of patients comorbid for addiction and other psychiatric disorders.
Brady KT, Verduin ML, Tolliver BK. Brady KT, et al. Curr Psychiatry Rep. 2007 Oct;9(5):374-80. doi: 10.1007/s11920-007-0048-0. Curr Psychiatry Rep. 2007. PMID: 17915076 Review.
Predictors of antipsychotics switching among ambulatory patients with schizophrenia in Ethiopia: a multicenter hospital-based cross-sectional study.
Kiflu M, Azale T, Gubae K, Agegnew Wondm S, Mebratu E, EliasErgena A, Abubeker O, Mekonnen GA. Kiflu M, et al. Ann Gen Psychiatry. 2024 Jan 3;23(1):2. doi: 10.1186/s12991-023-00472-z. Ann Gen Psychiatry. 2024. PMID: 38172853 Free PMC article.
Using a randomized controlled trial to test whether modifications to contingency management improve outcomes for heavy drinkers with serious mental illness.
Oluwoye O, Skalisky J, Burduli E, Chaytor NS, McPherson S, Murphy SM, Herron J, Hirchak K, Burley M, Ries RK, Roll JM, McDonell MG. Oluwoye O, et al. Contemp Clin Trials. 2018 Jun;69:92-98. doi: 10.1016/j.cct.2018.04.010. Epub 2018 Apr 20. Contemp Clin Trials. 2018. PMID: 29680318 Free PMC article.
Pharmacological treatment of schizophrenia and co-occurring substance use disorders.
Smelson DA, Dixon L, Craig T, Remolina S, Batki SL, Niv N, Owen R. Smelson DA, et al. CNS Drugs. 2008;22(11):903-16. doi: 10.2165/00023210-200822110-00002. CNS Drugs. 2008. PMID: 18840032 Review.
Risperidone versus other antipsychotics for people with severe mental illness and co-occurring substance misuse.
Temmingh HS, Williams T, Siegfried N, Stein DJ. Temmingh HS, et al. Cochrane Database Syst Rev. 2018 Jan 22;1(1):CD011057. doi: 10.1002/14651858.CD011057.pub2. Cochrane Database Syst Rev. 2018. PMID: 29355909 Free PMC article.

See all "Cited by" articles

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- Ovid Technologies, Inc.
- Wolters Kluwer
Medical
- MedlinePlus Consumer Health Information
- MedlinePlus Health Information